Combined Use of the Adenosine A 2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

By Kanda T.   Jackson M.J.   Smith L.A.   Pearce R.K.B.   Nakamura J.   Kase H.   Kuwana Y.   Jenner P.  

Experimental Neurology, Vol. 162, Iss. 2, 2000-04 ,pp. : 321-327

Elsevier

Access to resources Recommend Favorite

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates

By Kuoppamäki M.   Al-Barghouthy G.   Jackson M. J.   Smith L. A.   Quinn N.   Jenner P.  

Journal of Neural Transmission, Vol. 114, Iss. 9, 2007-09 ,pp. : 1147-1153

Springer Publishing Company

Access to resources Recommend Favorite

Nicotine Alone and in Combination with l-DOPA Methyl Ester or the D 2 Agonist N-0923 in MPTP-Induced Chronic Hemiparkinsonian Monkeys

By Domino E.F.   Ni L.   Zhang H.  

Experimental Neurology, Vol. 158, Iss. 2, 1999-08 ,pp. : 414-421

Elsevier

Access to resources Recommend Favorite

Cholinergic manipulation of motor disability and l-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets

By Jackson M.   Swart T.   Pearce R.   Jenner P.  

Journal of Neural Transmission, Vol. 121, Iss. 2, 2014-02 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Cyto- and Chemoarchitecture of Basal Forebrain Cholinergic Neurons in the Common Marmoset (Callithrix Jacchus)

By Wu C.-K.   Hersh L.B.   Geula C.  

Experimental Neurology, Vol. 165, Iss. 2, 2000-10 ,pp. : 306-326

Elsevier

Access to resources Recommend Favorite